Industry Information

Urofollitropin Instructions【kangyuan】

  Urofollitropin, also known as human menopausal gonadotropin (hMG), is a medication used in fertility treatments. It is made of natural human hormones, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).

  Urofollitropin is typically administered via injection in the subcutaneous tissue or into a muscle. The dosage and frequency of injections are determined by a healthcare professional based on the patient’s individual needs and response to treatment.

Urofollitropin Instructions【kangyuan】

  Before using urofollitropin, patients should inform their healthcare provider of any medical conditions or medications they are taking. This medication should not be used by individuals with a history of ovarian cysts, abnormal vaginal bleeding, or certain hormone-related cancers.

  Common side effects of urofollitropin include abdominal swelling, bloating, headache, and dizziness. In rare cases, more serious side effects such as ovarian enlargement or rupture and blood clots may occur.

  Urofollitropin is typically used in combination with other fertility medications to stimulate the ovaries to produce multiple eggs, increasing the chances of successful fertilization and pregnancy.

  Patients should follow all instructions provided by their healthcare provider and report any unusual symptoms or side effects. It is important to undergo regular monitoring and testing during treatment to ensure the safety and effectiveness of urofollitropin.